NEWS

Advancements in Patient-Centered Care

Stay up to date with the latest advancements in oral oncolytics, medically-integrated oncology, and cancer care best practices.

Venetoclax (Venclexta®) Risk Stratification, Dosing, and Dispensing Procedure

September 22, 2018

Written By: Jon Suyko, PharmD, BCPS UCHealth Highlands Ranch Download Here Description: Venetoclax therapy requires particular parameters be closely followed to ensure optimal patient outcomes. This PQI will review appropriate risk stratification, dosing, and dispensing procedures.  These risk stratifications create special challenges for the dispensing of venetoclax. Some medium-risk and all high-risk patients may require […]
read more

American Society of Clinical Oncology Position Statement: Pharmacy Benefit Managers and Their Impact on Cancer Care

September 6, 2018

The purpose of this ASCO Position Statement is to provide a summary of issues our members have raised about the role of PBMs in oncology, to share questions that have surfaced about PBM practices and their impact on physicians and patients, to assert ASCO’s immediate position on key issues, and to highlight areas of concern […]
read more

Smilow Cancer Hospital – Yale New Haven Health

September 4, 2018

Mission Statement: The mission of the Department of Pharmacy is to provide high value, patient-centered care. We will promote best practices that drive safe, effective, and timely medication therapy through all transitions of care. We will cultivate collaboration, innovation, education and career growth through employee engagement and practice advancement initiatives.
read more

Billings Clinic Cancer Center

August 10, 2018

Mission Statement: Billings Clinic Cancer Center Mission: To provide leading-edge care for patients and their families. Billings Clinic Cancer Center Vision: To be nationally recognized for premier cancer care and the first choice for patients, their families, and referring providers. Billings Clinic Cancer Center Core Values: Optimism: We believe in creating an environment of optimism […]
read more

Missouri Cancer Associates

August 10, 2018

Mission Statement: Our Family. Caring for Yours. We’ll be there every step of the way. Our physicians and staff are committed to providing friendly, professional, patient-centered care with dignity and respect for all. Missouri Cancer Associates is a full service medical and radiation oncology and hematology practice made up of 14 physicians in Columbia and […]
read more

Memorial Cancer Institute

August 10, 2018

Mission Statement: Memorial Healthcare System’s mission is to heal the body, mind, and spirit of all those we touch. Our vision is that The Memorial Cancer Institute (MCI) is the preeminent cancer center in South Florida and have national and international recognition in an effort to treat and prevent cancer.
read more

Bassett Healthcare Network Bassett Medical Center

June 22, 2018

Mission Statement: Bassett Medical Center is a part of Bassett Healthcare Network, a healthcare system that strives to provide excellence in healthcare to rural communities across eight counties in central New York. Bassett Medical Center is an academic medical center that exists to offer a continuum of care for our patients in all service lines, […]
read more

Helping Patients Faced with CoPay Accumulator Changes

June 20, 2018

(Excerpt from drugchannels.net) Patients today are being asked to pay a significant share of prescription costs for more-expensive specialty drugs, because of high coinsurance amounts. Many patients also face a deductible for their prescriptions.These are either a combined medical-pharmacy benefit deductible or an annual prescription drug deductible that was separate from any general annual deductible. […]
read more

Taiho Oncology Eliminates Co-Pays for Many of the Patients Treated with LONSURF® (trifluridine and tipiracil)

June 16, 2018

PRINCETON, N.J., June 7, 2018 – Taiho Oncology, Inc. today announced that, in an effort to further support access for patients and their LONSURF® treatment, the co-pay for all dose strengths of LONSURF has been reduced from $30 to $0 per treatment cycle. The co-pay reduction, which took effect on May 1, 2018, is available […]
read more

Real-world analysis reinforces that Gilotrif® dose adjustments reduce the frequency and intensity of adverse drug reactions without impacting efficacy

June 5, 2018

RealGiDo study results showed median time on treatment and time to progression of 18.7 and 20.8 months, respectively, were not impacted by dose modifications with Gilotrif® (afatinib) as first-line therapyGilotrif safety profile observed in real-world setting showed that there were no new safety signals Ridgefield, Conn., May 31, 2018 – Boehringer Ingelheim today announced results […]
read more

ASCO Selects NCODA Abstract for Publication: Cost Avoidance & Waste Tracker

May 27, 2018

Out of 6,400+ total scientific abstracts, the American Society of Clinical Oncology selected an NCODA abstract for online publication for the 2018 ASCO Annual Meeting. Through the abstract titled: Cost avoidance through the medically integrated dispensary (MID) for oral chemotherapy: Utilizing the NCODA cost avoidance and waste tracker, we were able to present collective intervention […]
read more

New England Cancer Specialists

May 13, 2018

Mission Statement: New England Cancer Specialists (NECS) goal is our patients best outcomes. We strive to make life better for patients with cancer and blood disorders. Our core values are commitment, quality, respect, accountability, integrity, and innovation.
read more

RESOURCES

Cost Avoidance Waste Tracker

Positive Quality Interventions

PQI in Action

OCE Sheets

IVE Sheets

Treatment Support Kits

PQI Podcast

Members

Member Resources

OPTA

Committees

Member Login

Events

Webinars

Spring Forum

Oncology Institute

PSO Annual Meeting

Fall Summit

contact@ncoda.org

315-655-4640

P.O. Box 468
Cazenovia, NY 13035

NCODA is a 501(c)(3) Organization